Control group | TXA 250 mg | TXA 500 mg | p-value | |
---|---|---|---|---|
(n = 45) | (n = 45) | (n = 45) | ||
Blood loss outcome variables | ||||
Drainage blood loss✝ (ml) | 546.9 (273.0) | 475.0 (254.4) | 430.2 (224.0) | 0.09 |
Total hemoglobin loss✝ (g/dl) | 2.9 (1.2) | 2.2 (0.7)**a | 2.2 (0.7)**b | < 0.001** |
Calculated total blood loss✝ (ml) | 329.2 (119.4) | 239.7 (83.7)**a | 217.2 (86.1)**b | < 0.001** |
Packed red blood-cell transfusion | ||||
Blood transfusion use◆ | 10 (22%) | 6 (13%) | 0 (0%)** | 0.005* |